KYMR vs REGN: Which Stock is Better?
Side-by-side comparison of Kymera Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026
KYMR
Kymera Therapeutics Inc
$86.14
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | KYMR | REGN | Winner |
|---|---|---|---|
| Market Cap | $7.27B | $78.87B | REGN |
| P/E Ratio | N/A | 17.98 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | -0.6% | 0.0% | REGN |
| Gross Margin | -707.3% | 44.6% | REGN |
Analyze KYMR
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KYMR or REGN a better investment?
Comparing KYMR and REGN: Kymera Therapeutics Inc has a market cap of $7.27B while Regeneron Pharmaceuticals Inc has $78.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KYMR and REGN?
KYMR (Kymera Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KYMR or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KYMR or REGN?
REGN has higher revenue growth at 0.0% vs -0.6% for KYMR.
Which company is more profitable: KYMR or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -707.3% for KYMR.
Which is the larger company: KYMR or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.87B compared to $7.27B for KYMR.
Should I buy KYMR or REGN in 2026?
Both KYMR and REGN have investment merit. KYMR trades at $86.14 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KYMR and REGN stock?
Key differences: Market Cap ($7.27B vs $78.87B), P/E Ratio (N/A vs 18.0x), Revenue Growth (-0.6% vs 0.0%), Gross Margin (-707.3% vs 44.6%).